δ-opioid receptor-induced late preconditioning is mediated by cyclooxygenase-2 in conscious rabbits

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 283, Issue 5 52-5, 2002, Pages

  Kodani, Eitaro ^a   Xuan, Yu Ting ^a   Shinmura, Ken ^a   Takano, Hitoshi ^a   Tang, Xian Liang ^a   Bolli, Roberto ^a  

^a UNIVERSITY OF LOUISVILLE   (United States)

Author keywords

7 Benzylidenenaltrexone; BW 373U86; Ischemic reperfused

Indexed keywords

4 [ALPHA (4 ALLYL 2,5 DIMETHYL 1 PIPERAZINYL) 3 HYDROXYBENZYL] N,N DIETHYLBENZAMIDE; 7 BENZYLIDENENALTREXONE; CELECOXIB; CYCLOOXYGENASE 2; N (2 CYCLOHEXYLOXY 4 NITROPHENYL)METHANESULFONAMIDE; SIGMA OPIATE RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; HEART INFARCTION; HEART INFARCTION PREVENTION; HEART PROTECTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECEPTOR INTRINSIC ACTIVITY; STUNNED HEART MUSCLE;

EID: 0036839411     PISSN: 03636135     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpheart.00150.2002     Document Type: Article

References (74)

1. 6-(3-iodobenzyl)adenosine-5′-N-methyluronamide protects against myocardial stunning and infarction without hemodynamic changes in conscious rabbits. Circ Res 80: 800-809, 1997.
2. 3 adenosine receptors induces late preconditioning against infarction but not stunning in conscious rabbits (Abstract). J Mol Cell Cardiol 31: A10, 1999.
3. Banerjee S, Tang XL, Qiu Y, Takano H, Manchikalapudi S, Dawn B, Shirk G, and Bolli R. Nitroglycerin induces late preconditioning against myocardial stunning via a PKC-dependent pathway. Am J Physiol Heart Circ Physiol 277: H2488-H2494, 1999.
4. Baxter GF, Goma FM, and Yellon DM. Characterisation of the infarct-limiting effect of delayed preconditioning: Timecourse and dose-dependency studies in rabbit myocardium. Basic Res Cardiol 92: 159-167, 1997.
5. Baxter GF, Goma FM, and Yellon DM. Involvement of protein kinase C in the delayed cytoprotection following sublethal ischaemia in rabbit myocardium. Br J Pharmacol 115: 222-224, 1995.
6. Baxter GF, Marber MS, Patel VC, and Yellon DM. Adenosine receptor involvement in a delayed phase of myocardial protection 24 hours after ischemic preconditioning. Circulation 90: 2993-3000, 1994.
7. Bolli R. Common methodological problems and artifacts associated with studies of myocardial stunning in vivo. Basic Res Cardiol 90: 257-262, 1995.
8. Bolli R. The early and late phases of preconditioning against myocardial stunning and the essential role of oxyradicals in the late phase: An overview. Basic Res Cardiol 91: 57-63, 1996.
9. Bolli R, Bhatti ZA, Tang XL, Qiu Y, Zhang Q, Guo Y, and Jadoon AK. Evidence that late preconditioning against myocardial stunning in conscious rabbits is triggered by the generation of nitric oxide. Circ Res 81: 42-52, 1997.
10. Bolli R, Dawn B, Tang XL, Qiu Y, Ping P, Xuan YT, Jones WK, Takano H, Guo Y, and Zhang J. The nitric oxide hypothesis of late preconditioning. Basic Res Cardiol 93: 325-338, 1998.
11. Bolli R, Manchikalapudi S, Tang XL, Takano H, Qiu Y, Guo Y, Zhang Q, and Jadoon AK. The protective effect of late preconditioning against myocardial stunning in conscious rabbits is mediated by nitric oxide synthase. Evidence that nitric oxide acts both as a trigger and as a mediator of the late phase of ischemic preconditioning. Circ Res 81: 1094-1107, 1997.
12. Bolli R, Zughaib M, Li XY, Tang XL, Sun JZ, Triana JF, and McCay PB. Recurrent ischemia in the canine heart causes recurrent bursts of free radical production that have a cumulative effect on contractile function. A pathophysiological basis for chronic myocardial "stunning." J Clin Invest 96: 1066-1084, 1995.
13. Chang KJ, Rigdon GC, Howard JL, and McNutt RW. A novel, potent and selective nonpeptidic delta opioid receptor agonist BW373U86. J Pharmacol Exp Ther 267: 852-857, 1993.
14. Childers SR, Fleming LM, Selley DE, McNutt RW, and Chang KJ. BW373U86: A nonpeptidic delta-opioid agonist with novel receptor-G protein-mediated actions in rat brain membranes and neuroblastoma cells. Mol Pharmacol 44: 827-834, 1993.
15. Cohen MV, Yang XM, Liu GS, Heusch G, and Downey JM. Acetylcholine, bradykinin, opioids, and phenylephrine, but not adenosine, trigger preconditioning by generating free radicals and opening mitochondrial K(ATP) channels. Circ Res 89: 273-278, 2001.
16. Comer SD, McNutt RW, Chang KJ, De Costa BR, Mosberg HI, and Woods JH. Discriminative stimulus effects of BW373U86: A nonpeptide ligand with selectivity for delta opioid receptors. J Pharmacol Exp Ther 267: 866-874, 1993.
17. Elliott GT, Sowell CG, Walker EB, Weber PA, Moore J, and Gross GJ. The novel glycolipid RC-552 attenuates myocardial stunning and reduces infarct size in dogs. J Mol Cell Cardiol 32: 1327-1339, 2000.
18. ATP channels. Circ Res 84: 846-851, 1999.
19. Fryer RM, Hsu AK, and Gross GJ. ERK and p38 MAP kinase activation are components of opioid-induced delayed cardioprotection. Basic Res Cardiol 96: 136-142, 2001.
20. Fryer RM, Hsu AK, Nagase H, and Gross GJ. Opioid-induced cardioprotection against myocardial infarction and arrhythmias: Mitochondrial versus sarcolemmal ATP-sensitive potassium channels. J Pharmacol Exp Ther 294: 451-457, 2000.
21. Fryer RM, Pratt PF, Hsu AK, and Gross GJ. Differential activation of extracellular signal regulated kinase isoforms in preconditioning and opioid-induced cardioprotection. J Pharmacol Exp Ther 296: 642-649, 2001.
22. Fryer RM, Wang Y, Hsu AK, and Gross GJ. Essential activation of PKC-δ in opioid-initiated cardioprotection. Am J Physiol Heart Circ Physiol 280: H1346-H1353, 2001.
23. 1 and opioid delta 1 receptor agonists in iNOS-dependent (Abstract). Circulation 102: II-121, 2000.
24. Gutstein HB, Rubie EA, Mansour A, Akil H, and Woodgett JR. Opioid effects on mitogen-activated protein kinase signaling cascades. Anesthesiology 87: 1118-1126, 1997.
25. Haessler R, Kuzume K, Chien GL, Wolff RA, Davis RF, and Van Winkle DM. Anaesthetics alter the magnitude of infarct limitation by ischaemic preconditioning. Cardiovasc Res 28: 1574-1580, 1994.
26. Hill M, Takano H, Tang XL, Kodani E, Shirk G, and Bolli R. Nitroglycerin induces late preconditioning against myocardial infarction in conscious rabbits despite development of nitrate tolerance. Circulation 104: 694-649, 2001.
27. ATP channels. Am J Physiol Heart Circ Physiol 280: H377-H383, 2001.
28. Imagawa J, Baxter GF, and Yellon DM. Genistein, a tyrosine kinase inhibitor, blocks the "second window of protection"; 48 h after ischemic preconditioning in the rabbit. J Mol Cell Cardiol 29: 1885-1893, 1997.
29. 1 adenosine receptor. Basic Res Cardiol 96: 487-496, 2001.
30. 3 receptors. Am J Physiol Heart Circ Physiol 281: H959-H968, 2001.
31. 2 receptor is involved in the late phase of preconditioning in rabbit heart. J Mol Cell Cardiol 33: 1355-1362, 2001.
32. Kuzuya T, Hoshida S, Yamashita N, Fuji H, Oe H, Hori M, Kamada T, and Tada M. Delayed effects of sublethal ischemia on the acquisition of tolerance to ischemia. Circ Res 72: 1293-1299, 1993.
33. Li XY, McCay PB, Zughaib M, Jeroudi MO, Triana JF, and Bolli R. Demonstration of free radical generation in the "stunned" myocardium in the conscious dog and identification of major differences between conscious and open-chest dogs. J Clin Invest 92: 1025-1041, 1993.
34. ATP channels. Circ Res 84: 1396-1400, 1999.
35. Lou LG and Pei G. Modulation of protein kinase C and cAMP-dependent protein kinase by delta-opioid. Biochem Biophys Res Commun 236: 626-629, 1997.
36. Maldonado C, Qiu Y, Tang XL, Cohen MV, Auchampach J, and Bolli R. Role of adenosine receptors in late preconditioning against myocardial stunning in conscious rabbits. Am J Physiol Heart Circ Physiol 273: H1324-H1332, 1997.
37. Marber MS, Latchman DS, Walker JM, and Yellon DM. Cardiac stress protein elevation 24 hours after brief ischemia or heat stress is associated with resistance to myocardial infarction. Circulation 88: 1264-1272, 1993.
38. Marber MS and Yellon DM. Myocardial adaptation, stress proteins, and the second window of protection. Ann NY Acad Sci 793: 123-141, 1996.
39. McPherson BC and Yao Z. Morphine mimics preconditioning via free radical signals and mitochondrial K(ATP) channels in myocytes. Circulation 103: 290-295, 2001.
40. McPherson BC and Yao Z. Signal transduction of opioid-induced cardioprotection in ischemia-reperfusion. Anesthesiology 94: 1082-1088, 2001.
41. Miki T, Cohen MV, and Downey JM. Opioid receptor contributes to ischemic preconditioning through protein kinase C activation in rabbits. Mol Cell Biochem 186: 3-12, 1998.
42. Miyamae M, Fujiwara H, Kida M, Yokota R, Tanaka M, Katsuragawa M, Hasegawa K, Ohura M, Koga K, Yabuuchi Y, and Sasayama S. Preconditioning improves energy metabolism during reperfusion but does not attenuate myocardial stunning in porcine hearts. Circulation 88: 223-234, 1993.
43. Nogawa S, Forster C, Zhang F, Nagayama M, Ross ME, and Iadecola C. Interaction between inducible nitric oxide synthase and cyclooxygenase-2 after cerebral ischemia. Proc Natl Acad Sci USA 95: 10966-10971, 1998.
44. Ovize M, Przyklenk K, Hale SL, and Kloner RA. Preconditioning does not attenuate myocardial stunning. Circulation 85: 2247-2254, 1992.
45. Patel HH, Hsu A, Moore J, and Gross GJ. BW373U86, a delta opioid agonist, partially mediates delayed cardioprotection via a free radical mechanism that is independent of opioid receptor stimulation. J Mol Cell Cardiol 33: 1455-1465, 2001.
46. Ping P, Takano H, Zhang J, Tang XL, Qiu Y, Li RC, Banerjee S, Dawn B, Balafonova Z, and Bolli R. Isoform-selective activation of protein kinase C by nitric oxide in the heart of conscious rabbits: A signaling mechanism for both nitric oxide-induced and ischemia-induced preconditioning. Circ Res 84: 587-604, 1999.
47. Ping P, Zhang J, Qiu Y, Tang XL, Manchikalapudi S, Cao X, and Bolli R. Ischemic preconditioning induces selective translocation of protein kinase C isoforms epsilon and eta in the heart of conscious rabbits without subcellular redistribution of total protein kinase C activity. Circ Res 81: 404-414, 1997.
48. 1-opioid receptor antagonist: 7-Benzylidenenaltrexone. Eur J Pharmacol 218: 195-196, 1992.
49. Powell W. Rapid extraction of arachidonic acid metabolites from biological samples using octadecylsilyl silica. In: Methods in Enzymology, edited by Lands WEM and Smith WL. Orlando, FL: Academic, 1982, p. 466-477.
50. Pradelles P, Grassi J, and Maclouf J. Enzyme immunoassays of eicosanoids using acetylcholine esterase as label: An alternative to radioimmunoassay. Anal Chem 57: 1170-1173, 1985.
51. Qiu Y, Ping P, Tang XL, Manchikalapudi S, Rizvi A, Zhang J, Takano H, Wu WJ, Teschner S, and Bolli R. Direct evidence that protein kinase C plays an essential role in the development of late preconditioning against myocardial stunning in conscious rabbits and that epsilon is the isoform involved. J Clin Invest 101: 2182-2198, 1998.
52. Qiu Y, Rizvi A, Tang XL, Manchikalapudi S, Takano H, Jadoon AK, Wu WJ, and Bolli R. Nitric oxide triggers late preconditioning against myocardial infarction in conscious rabbits. Am J Physiol Heart Circ Physiol 273: H2931-H2936, 1997.
53. 1- but not μ- or κ-opioid receptors. Circulation 97: 1282-1289, 1998.
54. Schultz JE, Hsu AK, and Gross GJ. Morphine mimics the cardioprotective effect of ischemic preconditioning via a glibenclamide-sensitive mechanism in the rat heart. Circ Res 78: 1100-1104, 1996.
55. ATP channels. Am J Physiol Heart Circ Physiol 274: H909-H914, 1998.
56. Schwartz LM, Jennings RB, and Reimer KA. Premedication with the opioid analgesic butorphanol raises the threshold for ischemic preconditioning in dogs. Basic Res Cardiol 92: 106-114, 1997.
57. Shinmura K, Tang XL, Wang Y, Xuan YT, Liu SQ, Takano H, Bhatnagar A, and Bolli R. Cyclooxygenase-2 mediates the cardioprotective effects of the late phase of ischemic preconditioning in conscious rabbits. Proc Natl Acad Sci USA 97: 10197-10202, 2000.
58. Shinmura K, Xuan YT, Tang XL, Kodani E, Han H, Zhu Y, and Bolli R. Inducible nitric oxide synthase modulates cyclooxygenase-2 activity in the heart of conscious rabbits during the late phase of ischemic preconditioning. Circ Res 90: 602-608, 2002.
59. Smith WL, Garavito RM, and DeWitt DL. Prostaglandin endoperoxide H synthases (cyclooxygenases)-1 and -2. J Biol Chem 271: 33157-33160, 1996.
60. 3 adenosine receptors induce late preconditioning against infarction in conscious rabbits by different mechanisms. Circ Res 88: 520-528, 2001.
61. Takano H, Manchikalapudi S, Tang XL, Qiu Y, Rizvi A, Jadoon AK, Zhang Q, and Bolli R. Nitric oxide synthase is the mediator of late preconditioning against myocardial infarction in conscious rabbits. Circulation 98: 441-449, 1998.
62. ATP channels in late preconditioning against myocardial stunning and infarction in rabbits. Am J Physiol Heart Circ Physiol 279: H2350-H2359, 2000.
63. Takano H, Tang XL, Qiu Y, Guo Y, French BA, and Bolli R. Nitric oxide donors induce late preconditioning against myocardial stunning and infarction in conscious rabbits via an antioxidant-sensitive mechanism. Circ Res 83: 73-84, 1998.
64. Triana JF, Li XY, Jamaluddin U, Thornby JI, and Bolli R. Postischemic myocardial "stunning." Identification of major differences between the open-chest and the conscious dog and evaluation of the oxygen radical hypothesis in the conscious dog. Circ Res 69: 731-747, 1991.
65. Vane JR, Bakhle YS, and Botting RM. Cyclooxygenases 1 and 2. Annu Rev Pharmacol Toxicol 38: 97-120, 1998.
66. Wild KD, McCormick J, Bilsky EJ, Vanderah T, McNutt RW, Chang KJ, and Porreca F. Antinociceptive actions of BW373U86 in the mouse. J Pharmacol Exp Ther 267: 858-865, 1993.
67. Wu S, Li HY, and Wong TM. Cardioprotection of preconditioning by metabolic inhibition in the rat ventricular myocyte. Involvement of κ-opioid receptor. Circ Res 84: 1388-1395, 1999.
68. Xi L, Jarrett NC, Hess ML, and Kukreja RC. Essential role of inducible nitric oxide synthase in monophosphoryl lipid A-induced late cardioprotection: Evidence from pharmacological inhibition and gene knockout mice. Circulation 99: 2157-2163, 1999.
69. Xi L, Salloum F, Tekin D, Jarrett NC, and Kukreja RC. Glycolipid RC-552 induces delayed preconditioning-like effect via iNOS-dependent pathway in mice. Am J Physiol Heart Circ Physiol 277: H2418-H2424, 1999.
70. Xu H, Partilla JS, de Costa BR, Rice KC, and Rothman RB. Differential binding of opioid peptides and other drugs to two subtypes of opioid delta ncx binding sites in mouse brain: Further evidence for delta receptor heterogeneity. Peptides 14: 893-907, 1993.
71. Xuan YT, Tang XL, Banerjee S, Takano H, Li RC, Han H, Qiu Y, Li JJ, and Bolli R. Nuclear factor-κB plays an essential role in the late phase of ischemic preconditioning in conscious rabbits. Circ Res 84: 1095-1109, 1999.
72. Yang XM, Baxter GF, Heads RJ, Yellon DM, Downey JM, and Cohen MV. Infarct limitation of the second window of protection in a conscious rabbit model. Cardiovasc Res 31: 777-783, 1996.
73. Zhao L, Weber PA, Smith JR, Comerford ML, and Elliott GT. Role of inducible nitric oxide synthase in pharmacological "preconditioning" with monophosphoryl lipid A. J Mol Cell Cardiol 29: 1567-1576, 1997.
74. 1 receptors: Evidence from gene-knockout mice. Circulation 102: 902-907, 2000.